 Procainamide was approved by the US FDA on June 2, 1950 under the brand name Pronestyl.In 1951 Pronestyl was launched by Bristol-Myers Squibb, a pharmaceutical company in the US.Along with the discovery of procainamide came the discovery of its metabolite acecainide.